Old anxiety pill gets new test as opioid withdrawal aid
NCT ID NCT05511909
Summary
This study is testing if a medication called buspirone can help people with opioid addiction get through withdrawal more comfortably. One hundred adults will stay in a residential unit for 10-12 days to detox and will receive either buspirone, a different withdrawal medication (lofexidine), or a placebo. The main goal is to see if buspirone reduces withdrawal symptoms and cravings better than the other options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Behavioral Pharmacology Research Unit
Baltimore, Maryland, 21224, United States
Conditions
Explore the condition pages connected to this study.